Archive | Clinical Trials

Pembrolizumab vs Ipilimumab in Advanced Melanoma: Final Overall Survival Analysis of KEYNOTE-006

The final overall survival analysis of the phase III KEYNOTE-006 trial showed maintained superiority of pembrolizumab (Keytruda) vs ipilimumab (Yervoy) in advanced melanoma.

Read the full story

Posted in Melanoma In The News, Clinical Trials

Pembrolizumab Prolongs Overall Survival Compared With Ipilimumab in Melanoma

Regardless of dosing schedule, pembrolizumab demonstrated superior overall survival (OS) in comparison to ipilimumab in treating patients with advanced melanoma, according to a study published in The Lancet.

Read the full story

Posted in Melanoma In The News, Clinical Trials

Melanoma immunotherapy trials may not capture all toxicity data

Common Terminology Criteria for Adverse Events may not appropriately reflect immune-related adverse event severity, duration or timing, according to study results.

Read the full story

Posted in Melanoma In The News, Clinical Trials, Information

Discovery’s ‘First In Human’ Calls Much-Needed Attention To Clinical Trials

The Discovery Channel is in the middle of a three-part documentary called First in Human, which is shining a spotlight on the National Institutes of Health’s (NIH) Building 10, home to countless clinical trials since it opened in the 1950s.

Read the full story

Posted in Melanoma In The News, Clinical Trials, Patient Information

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories